Editorial
 108 DRUGS MORE UNDER DPCO   
 Wednesday, July 23, 2014 
 National Pharmaceutical Pricing Authority, early this month, brought 108 essential drugs more under the ambit of Drug Price Control Order, 2013 in addition to 348 drugs already under price control. 
  Past Editorial...  
TODAY'S NEWS
10:00  [IST]EU approves Alcon's Simbrinza eye drops to treat patient with glaucoma
09:00  [IST]AstraZeneca enters collaboration with Roche to develop plasma-based companion diagnostic test for AZD9291
more news >>
TOP NEWS
08:00  [IST]DCGI sets up Independent Expert Committee on Cardiology for trial deaths caused by drugs
08:00  [IST]Govt to frame trade policy to check huge imports of APIs from China, to strengthen domestic industry
08:00  [IST]CPA approaches state govt to empower drug inspectors in Chhatisgarh
08:00  [IST]Koya Healthcare evolves first of its kind APS therapy for diabetes patients
08:00  [IST]Metropolis study shows worrying trend of hepatitis B & C among youngsters
08:00  [IST]DCGI issues safety alert against use of Dendriatic cells for treatment of cancer
more news >>
YESTERDAY'S NEWS
18:00  [IST]Malvern completes MicroCal acquisition from GE; purchases Archimedes particle characterization system Affinity Biosensors
17:00  [IST]Innate Pharma completes enrollment in EffiKIR trial
16:00  [IST]Biocon chief seeks PM's intervention to solve issues being faced by pharma industry
15:00  [IST]Celsion reports positive interim data from phase 2 DIGNITY trial of ThermoDox in RCWBC
14:00  [IST]IHMA initiative to expand reach in China
09:40  [IST]Drug cos move Bombay HC challenging NPPA’s July 10 notification over price control
more news >>
INTERVIEW  
There is light at the end of the tunnel for the Indian clinical trial industry
Global clinical research organizations, leading international research centers and the bio pharma abroad are keen to conduct the human studies on the Indian patient population.
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |